Radiopharmaceutical Sciences
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
The aim of Radiopharmaceutical Sciences section of the journal is to provide academic and industrial communities with open access to publications on development of primarily novel radiopharmaceuticals and their application for fundamental and applied studies in biology and medicine. The development of the radiopharmaceuticals considers the design, synthesis and radiolabeling of the agents, their biological and preclinical evaluation, and finally clinical application. Contributions may concern targeted, pre-targeted, and non-targeted radiopharmaceuticals ranging from small molecules via peptides, peptidomimetics and antibodies and derivatives thereof to particles for their use in gamma scintigraphy including single photon emission tomography (SPECT), positron emission tomography (PET) and endoradiotherapy. The field of diagnostic imaging and (radio)pharmaceutical therapy guided by the diagnostic imaging is of strong interest. The related topics of physics, dosimetry, radiopharmacy, and hybrid imaging are also accepted. Download Section Flyer
Keywords
- Radiopharmaceuticals, agents, probes
- Radionuclides
- Imaging biomarkers
- Biological/preclinical evaluation
- First in-human clinical studies
- SPECT, PET/CT, PET/MRI
- Labeling chemistry
- Medicinal radiochemistry, (pre)clinical radiopharmacology, and radiopharmacy including GMP-compliant production
- Radiopharmaceutical drug development
- Radiotheranostics
- Hybrid imaging
- Organic molecules, high-molecular weight biomolecules, nano- and microparticles
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- 20th Anniversary of Pharmaceuticals—Advances in Radiopharmaceutical Sciences and Nuclear Medicine (Deadline: 20 August 2024)
- Recent Advancements in Radiochemistry and PET Radiotracer Development (Deadline: 25 August 2024)
- Development of Radiolabeled Peptides (Deadline: 25 August 2024)
- Radiopharmaceuticals and Nanotechnology (Deadline: 25 August 2024)
- The Medical Applications of Novel PET Radiopharmaceuticals (Deadline: 25 August 2024)
- Synthesis and Development of Novel Radiopharmaceuticals for Targeted Radiotherapy and Theranostics (Deadline: 22 September 2024)
- Antibody-Based Imaging and Targeted Therapy in Cancer (Deadline: 10 October 2024)
- PET and SPECT Molecular Imaging in Drug Development (Deadline: 10 November 2024)
- In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research: New Advances (Deadline: 25 November 2024)
- Molecular Imaging of the Tumor Microenvironment (Deadline: 30 November 2024)
- Past, Present and Future Radiotracer Techniques: Radiopharmaceuticals in Cancer Theranostics (Deadline: 22 December 2024)
- In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research, 2nd Edition (Deadline: 30 December 2024)
- Innovative Approaches to Radiopharmaceuticals: Advances in Design, Labeling, and Applications (Deadline: 31 January 2025)
- Challenges in the Development of PET and SPECT Radiotracers: Innovative Ideas with Negative Outcomes (Deadline: 25 September 2025)